Simplify. Automate. All Assay Data Analysis.
When analyzing assays, especially complex ones, challenges are present at every stage of the research lifecycle. How can you consolidate all assay data for any therapeutic modality or disease area on a single centralized platform and have customized analysis that can easily be applied at scale to facilitate collaboration across internal and external teams? How can you make unbiased decisions with full data oversight?
This is where Genedata comes in.
Our Customers
- All Assays. One Platform.
- Built for Data Interoperability. From the Start.
- Analysis Automation. From Reader to Reports.
- FAIR. AI-ready Data.
All Assays. One Platform.
- Streamline sample handling with full sample genealogy combined with barcode/labeling support and assay request management.
- Systematically harmonize all plate-based assays and analysis on a single platform and ensure data quality and reproducibility.
- Apply industry-leading pattern correction, advanced fitting algorithms, model selection, and multi-level QC – plus industry-vetted statistical models and best practices.
- Use intuitive and dynamic visualizations to assess results, identify problems, flag suspect data, and optimize analysis parameters with ease.
- Automatically assess samples across many assays to profile and identify hits.
- Make unbiased decisions with full oversight and traceability of critical data.
Built for Data Interoperability. From the Start.
- Capture raw data automatically, connect to assay analysis details, parameters, and results.
- Use out-of-the-box and customizable workflows to meet analysis and reporting requirements and easily exchange data across systems and groups.
- Overcome data-analysis bottlenecks with a first-in-class scalable data infrastructure built to handle highest data volumes.
- Provide all data to all stakeholders when they need it.
- Open architecture and robust and mature APIs with industry-leading documentation. Webservices for integration with existing IT ecosystem/infrastructure. Managed IT and hosting services available.
Analysis Automation. From Reader to Reports.
- Leverage a range of existing integrations with instruments and technologies for unattended data and metadata transfer, application of customized analysis, and reporting through existing infrastructure to downstream applications.
- Fully automated real-time and long-term assay performance and data quality monitoring.
- Rapid, on-the-fly adjustments of processing steps to trigger instant reanalysis of underlying data.
- Save time and reagents via automatic alerts when plate quality falls below a pre-set standard and pause runs if needed.
- Automatically trigger reanalysis of samples that meet pre-set result criteria.
FAIR. AI-ready Data.
- Automatically capture standardized metadata with globally unique and persistent IDs assuring maximum connectivity and searchability.
- Provide access in real-time to relevant users across the organization with fine-grained user management control.
- Ensure traceability, reusability, and reproducibility of all data over time to maximize value.
- Reduce costs and risks and accelerate pipeline productivity through FAIR data generation from the start.
- Leverage structured data and create AI-ready data products to drive innovation.
Customer Stories
AI-Based Assignment of Biacore SPR and Octet BLI Kinetic Profiles
Learn how Amgen implemented Genedata's AI-based classifier to automate binding profile assignment for Biacore SPR and Octet BLI curves with 95% accuracy, reducing manual effort and eliminating user bias.
Efficient Development of High-Content Imaging Assays by Deep Learning
Find out how Roche used Genedata's innovative workflows to streamline assay development and ensure consistent, high-quality results over time on automated platforms.
Streamlined Workflow for Characterization of Antibodies
Explore how Genmab and Genedata are automating protein quantification and purity assessment workflows to ensure efficient, high-quality analysis in antibody discovery and development, including bispecific antibodies.